Clinical lab industry faces a new test
from The Refill, by MM+M Hosted by Marc Iskowitz, Jack O'Brien, Lecia Bushak, Molly Huth
Dr. Bill Maurice, president and CEO of Mayo Collaborative Services and Mayo Clinic Laboratories, and board chair for the American Clinical Lab Association, describes the marketing challenge of demonstrating the value of the lab for healthcare, in conversation with Senior Editor Jack O’Brien. Senior Reporter Lecia Bushak recaps a new bill – the PREVAIL Act – that could affect pharma drug patents. Plus, the ongoing medical mystery surrounding President Joe Biden tops our Trends segment, along with the sentencing of Outcome Health’s former CEO and why Sam Altman and Arianna Huffington are building a personalized AI health coach. Is your team still treating AI like a side experiment while competitors use it to win? Cut through the buzzword fatigue. On November 12th, join hundreds of top marketers in New York City for AI Deciphered, presented by Campaign, MM+M, and PRWeek. Get real-world playbooks from leaders like Reddit’s Rob Gaige and Yahoo’s Matt Sanchez across dedicated tracks built for daily execution. Check us out at: mmm-online.com Follow us: YouTube: @MMM-online TikTok: @MMMnews Instagram: @MMMnewsonline Twitter/X: @MMMnews LinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.
Embed this episode
What this episode covers
Mayo Clinic Labs’ Dr. Bill Maurice, who’s also board chair for the American Clinical Lab Association, describes the marketing challenge of demonstrating the value of the lab for healthcare.
No transcript yet.